Your browser doesn't support javascript.
loading
Cost of treatment and consequences for chronic hepatitis B and C virus infection at a tertiary care hospital in Delhi.
Balasundaram, P; Tiwari, Vijay Kumar; Sherin Raj, T P.
Afiliação
  • Balasundaram P; Senior Resident, Government Medical College, Chandigarh, India.
  • Tiwari VK; Professor and Head, Department of Planning and Evaluation, The National Institute of Health and Family Welfare, New Delhi, India.
  • Sherin Raj TP; Assistant Research Officer, Department of Statistics and Demography, The National Institute of Health and Family Welfare, New Delhi, India.
Indian J Public Health ; 64(4): 409-412, 2020.
Article em En | MEDLINE | ID: mdl-33318395
ABSTRACT
Patient living with chronic viral hepatitis in India faces the high cost of treatment and impoverishment. The present study is aimed to assess the cost of treatment and economic consequences among chronically infected viral hepatitis patients at a tertiary care hospital in Delhi. The descriptive cross-sectional study was undertaken during October 2016-January 2017. Three hundred and eighty-nine participants were interviewed through a schedule for variables and assessing both direct and indirect costs. Costs of hospital expenditure were extracted from records available with patients or databases of the hospital. The average outpatient expenditure and the inpatient costs were calculated. Direct nonmedical costs were also included. The analysis revealed the total cost of treatment ranged from Rs. 16,600/-to Rs. 1,709,000/-with a median of Rs. 193,500 per year. The cost of treatment increased with the severity of the disease. The cost of treatment led to impoverishment in 52.8% of families and imposed a substantial economic burden and consequences on the patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Indian J Public Health Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Indian J Public Health Ano de publicação: 2020 Tipo de documento: Article